OHR Pharmaceutical Inc Share Price Nasdaq
Equities
US67778H2004
Biotechnology & Medical Research
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 1.56M 125M |
---|---|---|---|---|---|
Net income 2023 * | -12M -957M | Net income 2024 * | - | EV / Sales 2023 * | - |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-0.06
x | P/E ratio 2024 * |
-
| Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 86.62% |
Latest transcript on OHR Pharmaceutical Inc
Managers | Title | Age | Since |
---|---|---|---|
Todd Branning
CEO | Chief Executive Officer | 54 | 09/01/22 |
Dani Stoltzfus
PRN | Corporate Officer/Principal | - | - |
Ron Sarkar
PRN | Corporate Officer/Principal | - | 31/10/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dov Goldstein
CHM | Chairman | 56 | 11/07/19 |
Eric Richman
BRD | Director/Board Member | 63 | 11/07/19 |
Director/Board Member | 79 | 11/07/19 |
1st Jan change | Capi. | |
---|---|---|
+27.14% | 42.68B | |
-2.94% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+7.11% | 24.94B | |
-20.60% | 18.96B | |
+28.92% | 12.3B | |
-2.46% | 11.95B | |
-1.21% | 11.55B |